Detalles de la búsqueda
1.
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Blood
; 2024 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38687605
2.
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
Br J Haematol
; 200(4): 451-461, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335984
3.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36314897
4.
Antiphospholipid syndrome in cardiovascular disease and cancer.
Eur J Haematol
; 111(6): 834-843, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37667555
5.
A variant of KSHV-associated inflammatory cytokine syndrome in elderly men of Mediterranean descent.
Infection
; 2023 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113021
6.
Reproductive Failure and Thrombophilia: Not Enough Evidence for a Tight Bond.
Acta Haematol
; 145(2): 170-175, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34879375
7.
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Br J Haematol
; 192(6): 978-987, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862447
8.
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
Oncologist
; 26(7): 597-609, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33870594
9.
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group.
Hematol Oncol
; 39(2): 231-242, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33332639
10.
Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.
Ann Hematol
; 100(9): 2279-2292, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33523289
11.
The STAT signaling profile at the single cell level reveals novel insights in the association of FOXP3+ T regulatory cells with recurrent spontaneous abortions before and after lymphocyte immunotherapy.
Clin Immunol
; 210: 108261, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31689518
12.
The effect of transfusion on immune responses in thalassemia.
Blood Cells Mol Dis
; 83: 102425, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32244102
13.
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 105(3): 632-639, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171638
14.
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
Hematol Oncol
; 38(4): 541-553, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495951
15.
Concurrent visceral leishmaniasis and diffuse large B-cell lymphoma of the bone marrow.
Br J Haematol
; 204(4): 1129-1130, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185474
16.
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndrome.
Ann Hematol
; 98(6): 1383-1392, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30877373
17.
Immunoporosis: A New Role for Invariant Natural Killer T (NKT) Cells Through Overexpression of Nuclear Factor-κB Ligand (RANKL).
Med Sci Monit
; 25: 2151-2158, 2019 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30903656
18.
The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.
Hematol Oncol
; 36(4): 693-700, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30129144
19.
Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.
Hematol Oncol
; 36(4): 645-650, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882363
20.
The prognostic value of monosomal karyotype (MK) in higher-risk patients with myelodysplastic syndromes treated with 5-Azacitidine: A retrospective analysis of the Hellenic (Greek) Myelodysplastic syndromes Study Group.
Am J Hematol
; 93(7): 895-901, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29659040